TheNote.app
Sign In
Sign Up
RSS GSK press releases
GSK announces positive results from phase III trial of Nucala (mepolizumab) in COPD
GSK announces positive headline results of MATINEE, the phase III clinical trial evaluating Nucala (mepolizumab) in adults with COPD.
www.gsk.com
www.gsk.com